DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Filaminast

Filaminast

  • Supplementary Information

    Supplementary Information

  • Lung Inflammation and Atopy Muscarinic Receptor Expression

    Lung Inflammation and Atopy Muscarinic Receptor Expression

  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances

    The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances

  • Structural Basis for the Activity of Drugs That Inhibit Phosphodiesterases

    Structural Basis for the Activity of Drugs That Inhibit Phosphodiesterases

  • (12) United States Patent (10) Patent No.: US 9.254.262 B2 Casado Et Al

    (12) United States Patent (10) Patent No.: US 9.254.262 B2 Casado Et Al

  • PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev

    PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

  • A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum

    A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum

  • Combinations Comprising Antimuscarinic Agents and PDE4 Inhibitors

    Combinations Comprising Antimuscarinic Agents and PDE4 Inhibitors

  • Cyclic AMP-Specific Pdes: a Promising Therapeutic Target For

    Cyclic AMP-Specific Pdes: a Promising Therapeutic Target For

  • WO 2013/167743 Al 14 November 2013 (14.11.2013) P O P C T

    WO 2013/167743 Al 14 November 2013 (14.11.2013) P O P C T

  • Aclidinium for Use in Improving the Quality of Sleep in Respiratory Patients

    Aclidinium for Use in Improving the Quality of Sleep in Respiratory Patients

  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

    Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

  • (12) Patent Application Publication (10) Pub. No.: US 2013/0252924 A1 Penninger Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2013/0252924 A1 Penninger Et Al

  • Novel Methods Neue Verfahren Nouvelles Méthodes

    Novel Methods Neue Verfahren Nouvelles Méthodes

  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

    Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

  • FMO3 Inhibitors for Treating Pain

    FMO3 Inhibitors for Treating Pain

  • Pharmaabkommen A1 E

    Pharmaabkommen A1 E

Top View
  • Customs Tariff - Schedule Xxi - 1
  • ABCD of the Phosphodiesterase Family: Interaction and Differential Activity in COPD
  • Literature Search Strategy for Treatment of Stable
  • Human Neurogenesis Assay: Ramelteon
  • US8088935.Pdf
  • Nitric Oxide Releasing Amino Acid Ester
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • Phosphodiesterases As Drug Targets (Handbook of Experimental
  • Pyrrolotriazinone Derivatives As PI3K Inhibitors
  • WO 2013/106547 Al 18 July 2013 (18.07.2013) P O P C T
  • Customs Tariff - Schedule
  • Pharmaceutical Appendix to the Tariff Schedule 2
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • Phosphodiesterase Inhibitors As a Therapeutic Approach to Neuroprotection and Repair
  • Pharmaceutical Appendix to the Tariff Schedule 2
  • Pharmaceuticals Appendix
  • Schedule Clxxiii - European Union
  • (12) Patent Application Publication (10) Pub. No.: US 2010/0022563 A1 Henkin (43) Pub


© 2024 Docslib.org    Feedback